Hearing:
“Unsustainable Drug Prices: Testimony from the CEOs (Part II).”
Committee on Oversight and Reform
Thursday, October 1, 2020 (10:00 AM)
2154 RHOB
Washington, D.C.
This is a two-part hearing on Sept. 30 and Oct. 1st.
This is hybrid in person/remote hearing.
Witnesses
Mr. Robert Bradway
Chairman and Chief Executive Officer, Amgen Inc.
Added
09/28/2020 at 01:52 PM
- Witness Statement
[PDF]
Added
10/01/2020 at 01:13 PM
Mr. Thomas Kendris
U.S. Country President, Novartis AG
Added
09/28/2020 at 01:52 PM
- Witness Statement
[PDF]
Added
10/01/2020 at 01:13 PM
Mr. Mark Trudeau
President and Chief Executive Officer, Mallinckrodt Pharmaceuticals
Added
09/28/2020 at 01:52 PM
- Witness Statement
[PDF]
Added
10/01/2020 at 01:13 PM
Support Documents
- Notice
[PDF]
Added
09/22/2020 at 09:31 AM
- Memo
[PDF]
Added
09/25/2020 at 03:59 PM
- UC - Rep Maloney - Letter from the Mayor of Rockford, Illinois, Thomas McNamara
[PDF]
Added
11/12/2020 at 11:16 AM
Hearing Record
- Attendance
[PDF]
Added
10/02/2020 at 01:01 PM
- Questions for the Record from Chairwoman Maloney and Rep Porter to Bradway.
[PDF]
Added
10/30/2020 at 11:51 AM
- QFR Responses to Chairwoman Maloney and Rep Porter from Bradway at Amgen
[PDF]
Added
10/30/2020 at 11:51 AM
- Hearing Transcript
[PDF]
Added
11/30/2021 at 02:19 PM
First Published:
September 22, 2020 at 09:31 AM
Last Updated:
November 30, 2021 at 02:19 PM